Eflucimibe
Eflucimibe (F 12511) is a new acyl-coenzyme A cholesterol O-acyltransferase (ACAT) inhibitor. Eflucimibe can be used in the research of atherosclerosis[1].
Product Specifications
CAS Number
202340-45-2
Product Name Alternative
F 12511
UNSPSC
12352005
Target
Acyltransferase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/eflucimibe.html
Purity
98.60
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CC(C(C)=C(C(C)=C1)O)=C1NC([C@H](C2=CC=CC=C2)SCCCCCCCCCCCC)=O
Molecular Formula
C29H43NO2S
Molecular Weight
469.72
References & Citations
[1]Nathalie Mesplet, et al. Analysis of eflucimibe and related impurities by highly sensitive liquid chromatography-electrospray-tandem mass spectrometry. The Journal of Separation Science. 2003.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A04821-100 100 µL
Fatty acid binding protein 2 Antibody, mAb, Rabbit
Sign In for Pricing
View Details 
JN122014-01 50 µg
Anti-Borreliella burgdorferi DbpA Polyclonal Antibody
Sign In for Pricing
View Details JN122014-02 100 µg
Anti-Borreliella burgdorferi DbpA Polyclonal Antibody
Sign In for Pricing
View Details 
GTR15088061 1 Vial
Lentiviral human AKT2 shRNA (UAS) - Lentiviral human AKT2 shRNA (UAS) (25)
Sign In for Pricing
View Details